OK a serious post for once in a blue moon.
Us plebs on
OK a serious post for once in a blue moon.
Us plebs on an anonymous message board are semi-intelligent enough to understand that no matter what the EFFING EFFDA says, LL is the safest therapeutic out there that WORKS against CV19 for most sufferers. There's been enough anecdotal evidence that we feel comfortable in making this conclusion.
Parlaying this do the rest of the world and assuming most are as semi-intelligent or more than us, its easy enough to come to the conclusion that the start of the Brazil trial is the start of the final lap before the scientific community gives LL its deserved crown. No doubt the EFFING EFFDA may still try to cry foul, but at that point, they'll be largely ignored and even more exposed for the corrupt institution its become (the bureaucrats within that organization actually approved an Alzheimers drug against the unanimous recommendation against it by their own scientists!).
Given all the anecdotal evidence thus far, I liken waiting for an EUA before making LL available to the general public to waiting for the green light at a signalized intersection in the middle of a flat desert with no cars in unobstructed sight for miles around....and the light's been green for 5 minutes, but feels like days.
4
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A Grand Gathering of Robotics Minds Walking into KINTEX, Seoul's suburban behemoth of an exhibition center, you'll find a buzz that rivals the excitement of a stock floor on earnings day. It's ROBOTWORLD 2026, a stage set for tech titans and ambitious startups alike, all throwing in their chips on AI and robotics. From November 4th to 7th, 402 companies hailing from 17...
Continue Reading
Synova and Eventus: A Powerful Partnership If you've ever traded a share or two, you know the name of the game is risk management. Step into Synova Global's latest move, and you'll see a gamble worth watching closely. This time around, Synova has tapped Eventus to bring their Validus trade surveillance platform into the fold. Now, Eventus and its star player, Validus,...
Continue Reading
Let's Scrutinize These Big Transactions Alright, let's cut to the chase. We're seeing some big moves from Option Care Health, PTC Inc., and RXO Inc. that have us wondering if the shareholders are getting the short end of the stick. That's what Halper Sadeh LLC seems to think. They're rolling up their sleeves, investigating whether these companies have tossed aside their...
Continue Reading
Digging Into Holiday Wellness Gifts In this age where peace can feel as elusive as a pot of gold, gifting something that whispers serenity and comfort has its charm. Enter Rare Cannabinoid Company, a Hawaii-based brand, weaving from their cannabinoid blend a holiday gift guide designed to infuse calm into the season's chaos. Now, that's something. A Unique Take on Holiday...
Continue Reading
Alfa Laval's Vision for the Future Alfa Laval is gearing up for a dynamic Capital Markets Day on November 18, 2026. The Swedish engineering giant, renowned for heat transfer, separation, and fluid handling solutions, is setting the stage to outline bold strategies and ambitious targets. Investors should pay attention, as the company's roadmap charts a course towards a SEK...
Continue Reading
The Thanksgiving Playbook Nobody Wanted Sacramento's corridors are buzzing with electric tension. And why? It's not some trivial turkey drama but a simmering scandal over two utility giants trying to sneak a liability cap into law faster than you can ask for a second slice of pumpkin pie. PG&E and Edison have a little secret—a covert strategy to limit shareholder...
Continue Reading
Pyramid Pharma: Breaking New Ground in Blood Cancer Treatments There's a new player making waves in the battle against rare blood cancers: Pyramid Pharma Services. This U.S.-based contract development and manufacturing organization is stepping up its game by finessing a cartridge-based product designed to treat those rare and tricky blood maladies. The canvas? A...
Continue Reading
Trouble on the Horizon for Baidu Shareholders If you've got a pulse in the world of stock trading, you've likely caught wind of the storm brewing over at Baidu, Inc. (NASDAQ: BIDU). We're talking some heavy-duty allegations of securities fraud, and a class action lawsuit that's got investors scrutinizing their portfolios like never before. The lawsuit's been filed in the...
Continue Reading
Mining Moves and Market Churn Dusted off my boots and took a gander at Svea Mining AB. They’re a Swedish outfit that's rustling up some gold, copper, and silver out in the wilds of Northern Sweden. Now, they've got DNB and Carnegie stepping in as liquidity providers. Let me chew on this for a minute—why does a miner need a liquidity provider, you ask? It’s all about...
Continue Reading
Diving Into Quantum Cryptography for Blockchain Instanodes is throwing down the gauntlet for the blockchain crowd as the field of quantum computing edges ever closer to unsettling the cryptographic order. This company's latest play? Post-quantum account engineering for major players like Ethereum and Solana. And it's not just tinkering—they're giving the status quo a...
Continue Reading
Top 5 Most Recently Viewed Articles
U.S. Gold Corp. to Attend Prominent Industry Conference U.S. Gold Corp. (NASDAQ: USAU) is gearing up for a significant event as it announces its participation in the annual ROTH Conference for Growth Companies. This year's conference promises to be a remarkable gathering, bringing together influential voices from various sectors, showcasing innovations and insights into...
Continue Reading
Why Investors Look for Dividend Stocks Plenty of investors chase growth across stocks, bonds, ETFs—you name it. But if you’re focused on income, the goal shifts: you want steady cash coming in from investments you can buy and sell without much friction. That cash can come from interest on bonds, dividends from stocks, and other income-paying assets. A dividend is...
Continue Reading
OKX Wallet Expands Cross-Chain Journey with Upshift OKX, a pioneering global technology company, has significantly enhanced its offerings with an important announcement regarding its wallet. The recent integration with Upshift marks a pivotal step towards expanding decentralization in finance, bringing a range of new opportunities to users seeking cross-chain yield...
Continue Reading
Staffbase Recognized as a Leader in Intranet Solutions Staffbase, a prominent player in the employee communications sector, has achieved remarkable recognition once again. For the second consecutive year, the company has been named a Leader in the latest Gartner Magic Quadrant for Intranet Packaged Solutions. This is an impressive acknowledgment of their consistent...
Continue Reading
Intevac's Upcoming Financial Results Announcement Intevac, Inc. (Nasdaq: IVAC), known for its innovative thin-film processing systems, is preparing to announce its financial results for the third fiscal quarter of 2024. This significant event is scheduled for 1 p.m. PT, which corresponds to 4 p.m. ET, on a date that many shareholders and stakeholders will mark on their...
Continue Reading